Carmell Therapeutics CorporatioNASDAQ: CTCX

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Carmell Therapeutics Corporatio is in the Consumer Defensive sector

Carmell Therapeutics Corporatio is in the Household & Personal Products industry

Carmell Therapeutics Corporatio is headquartered in United States

Carmell Therapeutics Corporatio initial public offering (IPO) was on 23 September 2021

https://www.carmellcosmetics.com

No, Carmell Therapeutics Corporatio is not included in the S&P 500 index

No, Carmell Therapeutics Corporatio is not included in the NASDAQ 100 index

No, Carmell Therapeutics Corporatio is not included in the Dow Jones index

No data